Scholars Central

Research articlePublished 2016

In Ovo Progression of Borderline Ovarian Tumors

Authors: Meynier S, Undurraga M, Tille JC, Petignat P, Cohen M

Journal of Oncology Translational Research

Volume 2 · Issue 1 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Borderline ovarian tumors (BOTs) are generally considered to be non-invasive tumors with low malignancy potential. However, studies show that BOTs have the ability to progress to low-grade carcinomas and gain the potential to invade surrounding tissue and to metastasize. Here, we investigate whether a patient derived serous BOT (SBOT) could progress in low-grade serous carcinoma (LGSC) through in vitro and in vivo characterization. Methods: Ovarian cancer cell line from a SBOT, named OCAM, were isolated and characterized by PCR, migration assay and chick chorioallantoic membrane (CAM) assay. Results: OCAM cells express carcinoma characteristics and form a tumor in CAM. Moreover, OCAM cells get into membrane of chicken suggesting invasive properties. Conclusion: SBOTs could a precursor of LGSC involving consequences in adaptation of treatment provided by clinician.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Translational Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Meynier S”
  • BylineArticles whose byline prints “Undurraga M”
  • BylineArticles whose byline prints “Tille JC”
  • BylineArticles whose byline prints “Petignat P”
  • BylineArticles whose byline prints “Cohen M”